Objectives: The aim of the study was to evaluate the current status of gastric cancer surgery worldwide and update the changes compared to a previous survey in 2014. Methods: A cross-sectional survey was sent to surgical members of the International Gastric Cancer Association, pilot centers of the World Organization for Specialized Studies on Diseases of the Esophagus, and the Australian and New Zealand Gastric and Oesophageal Surgeons Association in addition to participants of the 2019 International Gastric Cancer and European Society for Diseases of the Esophagus congresses. Topics addressed included hospital volume, staging, perioperative treatment, surgical approach, anastomotic techniques, lymphadenectomy, and palliative management. Results: Between June 2019 and January 2020, 165 respondents from 44 countries completed the survey. In total, 80% worked in a hospital performing #x3e;20 gastrectomies annually. Staging laparoscopy and 18F-fluorodeoxyglucose positron emission tomography with computed tomography were preferred by 68 and 26% for advanced cancer, and 90% offered perioperative chemo(radio)therapy to patients. For early cancer, a minimally invasive surgical approach was preferred by 65% for distal and by 50% for total gastrectomy. For advanced cancer, this was preferred by 39% for distal and by 33% for total gastrectomy. And 84% favored a stapled anastomosis, and 14% created a jejunal pouch as reconstruction during total gastrectomy. A D2 lymphadenectomy was preferred for distal as well as for total gastrectomy, in both early (62 and 71%) and advanced (84 and 89%) cancer. Conclusion: This international survey demonstrates that perioperative chemotherapy and a D2 lymphadenectomy have now become the preferred treatment for gastric cancer. A minimally invasive surgical approach has gained popularity.
Dig Surg

中文翻译：

---

胃癌手术的全球实践：6 年更新

目的：本研究的目的是评估全球胃癌手术的现状，并更新与 2014 年先前调查相比的变化。方法：向国际胃癌协会的外科成员发送横断面调查，试点除了 2019 年国际胃癌和欧洲食管疾病学会大会的参与者之外，世界食管疾病专业研究组织、澳大利亚和新西兰胃和食管外科医生协会的中心。讨论的主题包括医院规模、分期、围手术期治疗、手术方法、吻合技术、淋巴结切除术和姑息治疗。结果：2019 年 6 月至 2020 年 1 月期间，来自 44 个国家/地区的 165 名受访者完成了调查。总共有 80% 的人在一家每年进行 #x3e; 20 次胃切除术的医院工作。68% 和 26% 的晚期癌症患者首选分期腹腔镜检查和 18F-氟脱氧葡萄糖正电子发射断层扫描和计算机断层扫描，90% 为患者提供围手术期化学（放射）治疗。对于早期癌症，65% 的远端胃切除术和 50% 的全胃切除术首选微创手术方法。对于晚期癌症，远端胃切除术的首选比例为 39%，全胃切除术的首选比例为 33%。84% 的人喜欢缝合吻合术，14% 的人在全胃切除术中创建空肠袋作为重建。在早期（62% 和 71%）和晚期（84% 和 89%）癌症中，远端和全胃切除术均首选 D2 淋巴结清扫术。结论：这项国际调查表明，围手术期化疗和 D2 淋巴结清扫术现已成为胃癌的首选治疗方法。微创手术方法已获得普及。
挖掘外科